<code id='2149591436'></code><style id='2149591436'></style>
    • <acronym id='2149591436'></acronym>
      <center id='2149591436'><center id='2149591436'><tfoot id='2149591436'></tfoot></center><abbr id='2149591436'><dir id='2149591436'><tfoot id='2149591436'></tfoot><noframes id='2149591436'>

    • <optgroup id='2149591436'><strike id='2149591436'><sup id='2149591436'></sup></strike><code id='2149591436'></code></optgroup>
        1. <b id='2149591436'><label id='2149591436'><select id='2149591436'><dt id='2149591436'><span id='2149591436'></span></dt></select></label></b><u id='2149591436'></u>
          <i id='2149591436'><strike id='2149591436'><tt id='2149591436'><pre id='2149591436'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:9678
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Former medical device CEO who sold dummy, plastic parts convicted of fraud
          Former medical device CEO who sold dummy, plastic parts convicted of fraud

          BRENDANSMIALOWSKI/AFPviaGettyImagesANewYorkjuryonWednesdayconvictedtheformerCEOofStimwave,acompanyth

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          The world needs the new pandemic treaty

          AdobeAttheheightoftheCovid-19pandemic,25headsofgovernmentissuedanextraordinarycallforanewinternation